Skip to main content
    A

    Abivax SA American Depositary Shares (ABVX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $83.61
    -3.97 (-4.53%)

    Market Cap: $7.67B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Abivax SA American Depositary Shares (ABVX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Abivax SA American Depositary Shares are Immunovant (IMVT), Vaxcyte (PCVX) and Axsome Therapeutics (AXSM). By market cap, Abivax SA American Depositary Shares ranks 6th of the 13 companies on this page; Summit Therapeutics (SMMT) is the largest at $11.32B.

    Peer Comparison

    ABVX's ROIC of -159.6% is below the peer median of -35.6%, and its revenue growth of -6.8% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Abivax SA American Depositary Shares (ABVX)$7.67BN/AN/A0.0%-159.6%-6.8%0.00%
    Immunovant Inc (IMVT)$7.07BN/AN/A0.0%N/A0.0%0.00%
    Vaxcyte Inc (PCVX)$10.03BN/AN/A0.0%N/A0.0%0.00%
    Axsome Therapeutics Inc (AXSM)$7.45BN/A8.6x-18.2%-48.1%51.9%0.00%
    Immunitybio Inc (IBRX)$6.40BN/A30.3x0.0%-780.5%52.3%0.00%
    Apogee Therapeutics, Inc. Common Stock (APGE)$10.22BN/AN/A0.0%N/A0.0%0.00%
    Spyre Therapeutics Inc. (SYRE)$9.88BN/AN/A0.0%N/A0.0%0.00%
    CG Oncology, Inc. Common stock (CGON)$6.65BN/AN/A0.0%-21.1%-3.7%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Kodiak Sciences Inc (KOD)$7.27BN/AN/A0.0%-1481.8%0.0%0.00%
    Erasca Inc (ERAS)$5.50BN/AN/A0.0%N/A0.0%0.00%
    Summit Therapeutics PLC (SMMT)$11.32BN/AN/A0.0%N/A-100.0%0.00%
    Travere Therapeutics Inc (TVTX)$4.86BN/A7.2x-18.7%-23.1%36.2%0.00%
    Peer median$7.36B87.2x9.9x0.0%-35.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Abivax SA American Depositary Shares, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Immunovant Inc (IMVT)
    Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
    IMVT competitors
    Vaxcyte Inc (PCVX)
    Vaxcyte, Inc., a pre-clinical biotech vaccine company, develops novel vaccines to prevent or treat infectious diseases globally.
    PCVX competitors
    Axsome Therapeutics Inc (AXSM)
    Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United...
    AXSM competitors
    Immunitybio Inc (IBRX)
    ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose...
    IBRX competitors
    Apogee Therapeutics, Inc. Common Stock (APGE)
    Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD)...
    Spyre Therapeutics Inc. (SYRE)
    Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by...
    SYRE competitors
    CG Oncology, Inc. Common stock (CGON)
    CG Oncology, Inc. is a clinical-stage biotechnology firm focused on developing groundbreaking cancer therapies, particularly through its lead product, CG0070...
    CGON competitors
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Kodiak Sciences Inc (KOD)
    Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing...
    KOD competitors
    Erasca Inc (ERAS)
    Erasca Inc. is a pioneering biopharmaceutical firm specializing in the development of targeted therapies for genetically defined cancers...
    ERAS competitors
    Summit Therapeutics PLC (SMMT)
    Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America...
    SMMT competitors
    Travere Therapeutics Inc (TVTX)
    Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification...
    TVTX competitors

    Frequently Asked Questions About ABVX

    Who are Abivax SA American Depositary Shares' main competitors?

    The companies most similar to Abivax SA American Depositary Shares include Immunovant (IMVT), Vaxcyte (PCVX), Axsome Therapeutics (AXSM), Immunitybio (IBRX) and Apogee Therapeutics, Inc. Common Stock (APGE), listed from the closest match.

    Who is Abivax SA American Depositary Shares' biggest competitor?

    Summit Therapeutics (SMMT) is the largest of the similar companies at $11.32B; Immunovant (IMVT) is the closest match by business profile, size, sector and industry.

    How does ABVX stock compare with its competitors?

    ABVX's net margin is 0.0% against a peer median of 0.0%.

    Which of Abivax SA American Depositary Shares' competitors pays a higher dividend?

    Abivax SA American Depositary Shares pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Abivax SA American Depositary Shares bigger than its competitors?

    No. Abivax SA American Depositary Shares is 6th by market cap among the 13 companies on this page; the largest is Summit Therapeutics (SMMT) at $11.32B.